Tonix Pharmaceuticals Holding Corp.

0.6553-0.0062-0.94%Vol 2.90M1Y Perf -96.10%
Jun 3rd, 2020 15:40 DELAYED
BID0.6551 ASK0.6555
Open0.6615 Previous Close0.6615
Pre-Market- After-Market0.66
 -0.66 -100.00%  - -%
Target Price
5.00 
Analyst Rating
Moderate Buy 2.00
Potential %
668.52 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Market Cap34.27M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
1.52 
Earnings Date
11th May 2020

Today's Price Range

0.64000.6615

52W Range

0.390017.90

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.30%
1 Month
-4.96%
3 Months
-43.46%
6 Months
-41.46%
1 Year
-96.10%
3 Years
-99.85%
5 Years
-99.99%
10 Years
-

TickerPriceChg.Chg.%
TNXP0.6553-0.0062-0.94
AAPL325.323.47001.08
GOOG1 437.70-1.5200-0.11
MSFT185.110.20000.11
XOM49.191.88003.97
WFC28.911.51005.51
JNJ148.670.42000.28
FB230.55-2.1700-0.93
GE7.340.29004.11
JPM104.555.62005.68
Earnings HistoryEstimateReportedSurprise %
Q01 2020-0.49-0.3724.49
Q04 2019-1.49-2.86-91.95
Q03 2019-4.35-5.69-30.80
Q02 2019-9.90-9.504.04
Q01 2019-12.80-12.90-0.78
Q04 2018-38.70-61.00-57.62
Q03 2018-65.00-57.0012.31
Q02 2018-76.00-73.003.95
Earnings Per EndEstimateRevision %Trend
6/2020 QR-0.2858.21Positive
9/2020 QR-0.2833.33Positive
12/2020 FY-1.1350.87Positive
12/2021 FY-0.7459.12Positive
Next Report Date-
Estimated EPS Next Report-0.49
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.90M
Shares Outstanding52.30M
Trades Count5.70K
Dollar Volume1.82M
Avg. Volume7.54M
Avg. Weekly Volume5.39M
Avg. Monthly Volume5.97M
Avg. Quarterly Volume6.11M

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) stock closed at 0.6615 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 2.98M shares and market capitalization of 34.27M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 12 people. Tonix Pharmaceuticals Holding Corp. CEO is Seth Lederman.

The one-year performance of Tonix Pharmaceuticals Holding Corp. stock is -96.1%, while year-to-date (YTD) performance is -43.46%. TNXP stock has a five-year performance of -99.99%. Its 52-week range is between 0.39 and 17.9, which gives TNXP stock a 52-week price range ratio of 1.52%

Tonix Pharmaceuticals Holding Corp. currently has a PE ratio of -, a price-to-book (PB) ratio of 1.09, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -125.45%, a ROC of -136.27% and a ROE of -137.97%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Tonix Pharmaceuticals Holding Corp., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.49 for the next earnings report. Tonix Pharmaceuticals Holding Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Tonix Pharmaceuticals Holding Corp. is Moderate Buy (2), with a target price of $5, which is +668.52% compared to the current price. The earnings rating for Tonix Pharmaceuticals Holding Corp. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Tonix Pharmaceuticals Holding Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Tonix Pharmaceuticals Holding Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.73, ATR14 : 0.06, CCI20 : -128.37, Chaikin Money Flow : -0.36, MACD : -0.02, Money Flow Index : 54.94, ROC : -4.70, RSI : 44.24, STOCH (14,3) : 14.85, STOCH RSI : 0.43, UO : 38.47, Williams %R : -85.15), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Tonix Pharmaceuticals Holding Corp. in the last 12-months were: Seth Lederman (Buy at a value of $23 180)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.

CEO: Seth Lederman

Teplephone: +1 212 980-9155

Address: 509 Madison Avenue, New York 10022, NY, USA

Number of employees: 12

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

62%38%

Bearish Bullish

53%47%

News

Stocktwits